First of Its Kind COVID-19 Facemask Uses Ultraviolet Light to Kill Germs While Leaving Face Uncovered
|
By HospiMedica International staff writers Posted on 10 Aug 2020 |
|
Illustration
Engineers at Pavvana (Denver, CO, USA) have developed a revolutionary protective mask that uses ultraviolet light to kill germs while leaving the face uncovered.
Pavvana's next-generation, patent-pending AirShield uses a curtain of air washed through UV-C sterilizing light to protect a user’s personal space at the same time it buffers others from the wearer, all while leaving the face open for work, play and family time. The Pavvana AirShield, worn on the forehead and consisting of UV-C light, air baffles, a rechargeable battery-powered fan and a head strap, is designed to kill 99.99% of airborne viruses and bacteria as the wearer breathes.
The AirShield is the first UV-C powered air shield produced for a mask, potentially replacing cloth and fabric-based face protections that haven't changed in decades. The Pavvana technology uses non-ozone producing UV-C bulbs that are encased so that no light escapes. The AirShield's rechargeable lithium ion battery can provide up to eight hours of comfortable protection, and there's nothing to clean or replace.
"We're excited and honored to bring this innovative, effective and comfortable product out into the world where it belongs," said Pavvana CEO Allbriton Robbins, a longtime designer for Fortune 500 firms. "It's a game-changer at a time when the daily routines of hundreds of millions of people have been torn up by a dangerous virus. We can help."
Related Links:
Pavvana
Pavvana's next-generation, patent-pending AirShield uses a curtain of air washed through UV-C sterilizing light to protect a user’s personal space at the same time it buffers others from the wearer, all while leaving the face open for work, play and family time. The Pavvana AirShield, worn on the forehead and consisting of UV-C light, air baffles, a rechargeable battery-powered fan and a head strap, is designed to kill 99.99% of airborne viruses and bacteria as the wearer breathes.
The AirShield is the first UV-C powered air shield produced for a mask, potentially replacing cloth and fabric-based face protections that haven't changed in decades. The Pavvana technology uses non-ozone producing UV-C bulbs that are encased so that no light escapes. The AirShield's rechargeable lithium ion battery can provide up to eight hours of comfortable protection, and there's nothing to clean or replace.
"We're excited and honored to bring this innovative, effective and comfortable product out into the world where it belongs," said Pavvana CEO Allbriton Robbins, a longtime designer for Fortune 500 firms. "It's a game-changer at a time when the daily routines of hundreds of millions of people have been torn up by a dangerous virus. We can help."
Related Links:
Pavvana
New
Gold Member
Handheld Blood Glucose Analyzer
STAT-Site
New
Patient Monitoring System
AlarmSense
New
POC Respiratory/Sore Throat Test
BIOFIRE SPOTFIRE (R/ST) Panel
Latest COVID-19 News
- Low-Cost System Detects SARS-CoV-2 Virus in Hospital Air Using High-Tech Bubbles
- World's First Inhalable COVID-19 Vaccine Approved in China
- COVID-19 Vaccine Patch Fights SARS-CoV-2 Variants Better than Needles
- Blood Viscosity Testing Can Predict Risk of Death in Hospitalized COVID-19 Patients
- ‘Covid Computer’ Uses AI to Detect COVID-19 from Chest CT Scans
- MRI Lung-Imaging Technique Shows Cause of Long-COVID Symptoms
- Chest CT Scans of COVID-19 Patients Could Help Distinguish Between SARS-CoV-2 Variants
- Specialized MRI Detects Lung Abnormalities in Non-Hospitalized Long COVID Patients
- AI Algorithm Identifies Hospitalized Patients at Highest Risk of Dying From COVID-19
- Sweat Sensor Detects Key Biomarkers That Provide Early Warning of COVID-19 and Flu
- Study Assesses Impact of COVID-19 on Ventilation/Perfusion Scintigraphy
- CT Imaging Study Finds Vaccination Reduces Risk of COVID-19 Associated Pulmonary Embolism
- Third Day in Hospital a ‘Tipping Point’ in Severity of COVID-19 Pneumonia
- Longer Interval Between COVID-19 Vaccines Generates Up to Nine Times as Many Antibodies
- AI Model for Monitoring COVID-19 Predicts Mortality Within First 30 Days of Admission
- AI Predicts COVID Prognosis at Near-Expert Level Based Off CT Scans
Channels
Artificial Intelligence
view channel
Machine Learning Approach Enhances Liver Cancer Risk Stratification
Hepatocellular carcinoma, the most common form of primary liver cancer, is often detected late despite targeted surveillance programs. Current screening guidelines emphasize patients with known cirrhosis,... Read more
New AI Approach Monitors Brain Health Using Passive Wearable Data
Brain health spans cognitive and emotional functions and can fluctuate even in adults without diagnosed disease. Detecting early changes remains difficult in routine care and burdens specialty services... Read more
Critical Care
view channel
Noninvasive Monitoring Device Enables Earlier Intervention in Heart Failure
Hospitalizations for heart failure with preserved ejection fraction (HFpEF) remain common because lung congestion often worsens before symptoms prompt treatment changes. Missed early decompensation... Read more
Automated IV Labeling Solution Improves Infusion Safety and Efficiency
Medication administration in high-acuity settings is often complicated by multiple concurrent infusions, making accurate line identification essential. In a 10-hospital intensive care unit study, 60% of... Read more
Surgical Techniques
view channel
Continuous Monitoring with Wearables Enhances Postoperative Patient Safety
Postoperative hypoxemia on general surgical wards is common and often missed by intermittent vital sign checks. Undetected low oxygen levels can delay recovery and raise the risk of complications that... Read more
New Approach Enables Customized Muscle Tissue Without Biomaterial Scaffolds
Volumetric muscle loss is a traumatic loss of skeletal muscle that often leads to permanent functional impairment and limited reconstructive options. Current experimental strategies struggle to deliver... Read more
Patient Care
view channel
Wearable Sleep Data Predict Adherence to Pulmonary Rehabilitation
Chronic obstructive pulmonary disease (COPD) is a long-term lung disorder that makes breathing difficult and often disturbs sleep, reducing energy for daily activities. Limited engagement in pulmonary... Read more
Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care
More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more
Health IT
view channel
EMR-Based Tool Predicts Graft Failure After Kidney Transplant
Kidney transplantation offers patients with end-stage kidney disease longer survival and better quality of life than dialysis, yet graft failure remains a major challenge. Although a successful transplant... Read more
Printable Molecule-Selective Nanoparticles Enable Mass Production of Wearable Biosensors
The future of medicine is likely to focus on the personalization of healthcare—understanding exactly what an individual requires and delivering the appropriate combination of nutrients, metabolites, and... Read more
Business
view channel
GE HealthCare Leads Major European Initiative to Advance Cardio-Oncology Care
Cardiovascular complications are increasingly recognized among people undergoing or recovering from cancer treatment, driven by pre‑existing disease and the cardiotoxic effects of chemotherapy, radiotherapy,... Read more
